These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34920954)

  • 1. Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay.
    Wooster M; McGuinness JE; Fenn KM; Singh VM; Franks LE; Lee S; Cieremans D; Lassman AB; Hershman DL; Crew KD; Accordino MK; Trivedi MS; Iwamoto F; Welch MR; Haggiagi A; Schultz RD; Huynh L; Sales E; Fisher D; Mayer JA; Kreisl T; Kalinsky K
    Clin Breast Cancer; 2022 Jun; 22(4):e457-e462. PubMed ID: 34920954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
    Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
    Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
    Barbour AB; Blouw B; Taylor LP; Graber JJ; McGranahan T; Blau M; Halasz LM; Lo SS; Tseng YD; Venur V; Yang JT
    J Neurooncol; 2024 May; 167(3):509-514. PubMed ID: 38441840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide
    Puri S; Malani R; Chalmers A; Kerrigan K; Patel SB; Monynahan K; Cannon L; Blouw B; Akerley W
    Neurooncol Adv; 2024; 6(1):vdad150. PubMed ID: 38196737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy.
    Kumthekar PU; Blouw B; Corkos P; Nagpal S; Tripathy A; Piccioni D; Youssef M
    Front Oncol; 2024; 14():1402651. PubMed ID: 38826788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
    Park IH; Kwon Y; Ro JY; Lee KS; Ro J
    Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
    Lin Y; Li H; Huang M; Yin Z; Wu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
    Nie N; Zhou H; Zhang K; Liu L; Luo N; Wang R; Li X; Zhu M; Hu C; Wang Y; Liu Z; Li L; He Y
    Thorac Cancer; 2022 Sep; 13(18):2574-2583. PubMed ID: 35896160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
    Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
    J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
    Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
    Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
    Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
    Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.
    Chiang CL; Lee CC; Huang HC; Wu CH; Yeh YC; Shen CI; Luo YH; Shiao TH; Chang HJ; Huang YT; Chen YM; Chou TY; Chiu CH
    Target Oncol; 2021 Mar; 16(2):207-214. PubMed ID: 33566300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.
    Ge M; Zhan Q; Zhang Z; Ji X; Zhou X; Huang R; Liang X
    BMC Cancer; 2019 Feb; 19(1):143. PubMed ID: 30755180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
    Lin Y; Yu T; Li H; Yin Z; Guo A
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
    Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
    BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
    Darlix A; Cayrefourcq L; Pouderoux S; Menjot de Champfleur N; Bievelez A; Jacot W; Leaha C; Thezenas S; Alix-Panabières C
    Clin Chem; 2022 Oct; 68(10):1311-1322. PubMed ID: 35953885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.
    Chen X; Bai K; Zhang Y; Xu Y; Huo Y; Wang S; Zou Y; Qi X; Guo R; Ou Q; Liu D; Yin S; Chen S; Bu H
    J Transl Med; 2023 May; 21(1):296. PubMed ID: 37131253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.